approved EB-2 (NIW)

Ph.D. Candidate

Nanoengineering · China · 2025-02-26

Processing Time
30 days
Decision Date
2025-02-26
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on applying and advancing cutting-edge 3D printing technologies to develop in vitro models of diseases and engineered designs for medical and environmental applications. Her work specifically focuses on 3D bioprinting methods, photosynthetic living biomaterials for pollutant degradation, artificial coral structures, and succulent-based microneedles for sustained drug release.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses pressing global challenges in medicine and environmental sustainability through innovative 3D bioprinting technologies.

2 Well-positioned to Advance the Endeavor Met

The petitioner's education, expertise, and record of 271 citations and 8 peer-reviewed articles demonstrate she is well-positioned to succeed.

3 Balance of Interests Met

The petitioner's major contributions and the national interest served by her research make her an invaluable asset, justifying the waiver.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 8 peer-reviewed journal articles and conference papers which garnered 271 citations. Evidence included proof of funding from the National Institutes of Health (NIH) and National Science Foundation (NSF), as well as two expert recommendation letters. These factors satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Biomedical Engineer

Engineering · China

WeGreened EB-2 (NIW) approved
New York 7 days 2023-12-14
The petitioner proposes to continue research on using microfluidics, organ-on-chip, and 3D bioprinting techniques to develop novel tissue engineering models for the lymphatic and ophthalmic systems. This work aims to identify therapeutic targets for diseases and address the growing demand for tissue engineering solutions and the prevalence of lymphatic and ophthalmic diseases.

Others

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Pennsylvania 289 days 2025-02-28
The petitioner proposes to design novel biomaterials and wearable devices to advance personalized healthcare through continuous monitoring and early detection of chronic conditions. His work involves developing nanostructured materials for targeted drug delivery and tissue engineering, as well as creating flexible devices capable of capturing physiological signals for diagnosis.

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Arizona 62 days 2025-04-16
The petitioner proposes to engineer novel bacterial systems by integrating synthetic biology and microfluidics to create engineered living systems. This work aims to develop self-healing materials and precision drug delivery platforms for biomedical, biomanufacturing, and environmental applications. The research focuses on pioneering microbial innovations to advance the U.S. bioengineering sector.

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Michigan 655 days 2025-08-08
The petitioner proposes to develop new material characterization techniques to synthesize and describe novel materials for use in biomaterials and therapeutics. Her work focuses on innovative nanocomposite synthesis with large surface area and biocompatibility for drug delivery, wound healing, and anti-pathogen coatings. Additionally, she aims to study novel chemical derivatives to lay the groundwork for future treatments for Alzheimer’s disease.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-26.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 30 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist